Literature DB >> 2535100

Left ventricular mass changes with nicardipine therapy in essential hypertension.

P Gosse1, P Lacroix, R Roudaut, M Dallocchio.   

Abstract

Eighteen hypertensive patients (13 males, 5 females; age 48 +/- 13; diastolic blood pressure greater than 95 mmHg), either previously untreated or who had been off treatment for more than 3 months, underwent M-mode echocardiography before (DO) and after (D90) 3 months of nicardipine therapy (60-90 mg/day). All echocardiograms were read blind, and left ventricular mass (LVM) was calculated (Devereaux's formula). Blood pressure was significantly reduced after 3 months from 167 +/- 15/102 +/- 8 mmHg on DO to 152 +/- 16/92 +/- mmHg on D90 (p less than 0.001). The reduction in LVM was not significant: 266 +/- 95 g on DO, 247 +/- 78 g on D90. There was a trend to a higher (although nonsignificant) LVM reduction in patients with left ventricular hypertrophy at entry (-11%, n = 11) than in patients without left ventricular hypertrophy (-2%), n = 7).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2535100     DOI: 10.1007/bf01865511

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  22 in total

1.  High night blood pressure in treated hypertensive patients: not harmless.

Authors:  P Gosse; G Campello; R Roudaut; M Dallocchio
Journal:  Am J Hypertens       Date:  1988-07       Impact factor: 2.689

2.  The effect of nifedipine on arterial pressure and reflex cardiac control.

Authors:  R A McLeay; T J Stallard; R D Watson; W A Littler
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

3.  Improved left ventricular filling accompanies reduced left ventricular mass during therapy of essential hypertension.

Authors:  V E Smith; W B White; M K Meeran; M K Karimeddini
Journal:  J Am Coll Cardiol       Date:  1986-12       Impact factor: 24.094

4.  Effect of acebutolol on left ventricular hemodynamics and anatomy in systemic hypertension.

Authors:  B Trimarco; B Ricciardelli; N De Luca; M Volpe; A Veniero; A Cuocolo; M Condorelli
Journal:  Am J Cardiol       Date:  1984-03-01       Impact factor: 2.778

5.  Diltiazem-induced left ventricular mass regression in hypertensive patients.

Authors:  R J Weiss; B Bent
Journal:  J Clin Hypertens       Date:  1987-06       Impact factor: 3.738

6.  Vasodilators and regression of left ventricular hypertrophy. Hydralazine versus prazosin in hypertensive humans.

Authors:  F H Leenen; D L Smith; R M Farkas; R A Reeves; A Marquez-Julio
Journal:  Am J Med       Date:  1987-05       Impact factor: 4.965

7.  Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension.

Authors:  F G Dunn; W Oigman; H O Ventura; F H Messerli; I Kobrin; E D Frohlich
Journal:  Am J Cardiol       Date:  1984-01-01       Impact factor: 2.778

8.  Cardiac and haemodynamic effects of enalapril.

Authors:  F M Fouad; R C Tarazi; E L Bravo
Journal:  J Hypertens Suppl       Date:  1983-10

Review 9.  [Left ventricular hypertrophy of the hypertensive patient. Approach to its pathogenesis and consequences].

Authors:  P Gosse; M Dallocchio
Journal:  Ann Cardiol Angeiol (Paris)       Date:  1986-10-30

10.  Performance of primary and derived M-mode echocardiographic measurements for detection of left ventricular hypertrophy in necropsied subjects and in patients with systemic hypertension, mitral regurgitation and dilated cardiomyopathy.

Authors:  R B Devereux; P N Casale; P Kligfield; R R Eisenberg; D Miller; E Campo; D R Alonso
Journal:  Am J Cardiol       Date:  1986-06-01       Impact factor: 2.778

View more
  1 in total

Review 1.  Nicardipine. A review of its pharmacology and therapeutic efficacy in older patients.

Authors:  J E Frampton; D Faulds
Journal:  Drugs Aging       Date:  1993 Mar-Apr       Impact factor: 3.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.